期刊文献+

苯磺酸左旋氨氯地平片治疗原发性高血压的临床效果分析

下载PDF
导出
摘要 目的研究苯磺酸左旋氨氯地平对原发性高血压的治疗效果。方法临床纳入我院2014年2月至2016年2月期间收治的90例原发性高血压患者进行研究,按随机排列表法分为两组各45例。其中45例患者采用硝苯地平治疗作为对照组,另45例患者采用苯磺酸左旋氨氯地平治疗作为观察组。结果观察组、对照组总有效率分别为93.33%、86.67%,两组差异无统计学意义(P>0.05)。治疗前两组血压水平差异无统计学意义(P>0.05);治疗后观察组SBP、DBP水平低于对照组,差异有统计学意义(P<0.05)。观察组不良反应发生率仅为4.44%,低于对照组的17.78%,P<0.05。结论原发性高血压患者采用苯磺酸左旋氨氯地平治疗效果显著,有效控制血压,减少不良反应,值得临床推广应用。
作者 黎斌
出处 《现代医学与健康研究电子杂志》 2017年第4期61-,66,共2页 Modern Medicine and Health Research
  • 相关文献

参考文献3

二级参考文献25

  • 1梁小卫,罗兴才.氨氯地平分别与氯沙坦及依那普利治疗老年高血压病合并2型糖尿病疗效观察[J].医学信息(医学与计算机应用),2014,0(36):344-344. 被引量:2
  • 2Zhao D, Liu J, Wang W, et, al. Epidemiological transition of stroke in China: twenty - one - year observational study from the Sino - MONICA -Beijing Project[J]. Stroke, 2008,39(6) :1668 -1674.
  • 3Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta - analysis [J]. BMJ, 2002,325 (7374) :1202.
  • 4Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta - analysis [J]. Lancet, 2007, 369 (9576) :1876 -1882.
  • 5Rosa EM, Kramer C. Castrol association between coronary artery atherosclerosis and the intima - media thickness of the common carotid artery measured on ultrasonography [J]. Arq Bra Cardiol, 2003,80 ( 6) : 589 -592.
  • 6Haim M, Tanne D, Goldbourt U, et al. Serum homocysteine and long - term risk of myocardial infarction and sudden death in patients with coronaryheart disease [J]. Cardiology, 2007,107 (1) :52 - 56.
  • 7Biswas A, Ranjan R, Meena A, et, al. Homocystine levels, polymorphisms and the risk of ischemic stroke in young Asian Indians [J]. J Stroke Cerebrovasc Dis, 2009, 18 ( 20) : 103 - 11 o.
  • 8Tseng YL, Chang YY, Liu JS, et, al. Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance in stroke patients [J]. J Neurol Sci, 2009,284 ( 112) : 36 - 39.
  • 9Zanchetti A. Bond MG. Hennig M. et al. European Lacidipine Study on Atherosclerosis investigators. Calcium antagonist lacidipine slows down progression of asympomatic carotid atheroselerosis. Principal results of the European lacidipine study on Atherosclerosis ( ELSA). a randomized doubleblind , long - term trial [J]. Circulation. 2002. 106 (19) :2422 -2427.
  • 10The Emerging Risk Factors Collaboration.Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies[J]. The Lancet . 2010 (9733)

共引文献93

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部